2022
DOI: 10.2147/ppa.s355638
|View full text |Cite
|
Sign up to set email alerts
|

Patients’ Preference Between DPP4i and SGLT2i for Type 2 Diabetes Treatment: A Cross-Sectional Evaluation

Abstract: Purpose Despite newer type 2 diabetes (T2D) medications, patients do not always achieve metabolic targets, remaining at risk for cardiorenal complications. Therapeutic decisions are generally made by the healthcare team without considering patients’ preferences. We aimed to evaluate patients’ T2D treatment preference in two Latin-American countries between two different oral medication profiles, one resembling dipeptidyl peptidase-4 inhibitors (DPP4i) and another resembling sodium-glucose cotransp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 33 publications
0
1
0
Order By: Relevance
“…Patient preferences and WTP for improvements in diabetes treatment have been assessed using Discrete Choice Experiments (DCEs) in the US [23], the Netherlands [24] and Denmark [9], but few published studies have used DCEs to measure diabetes care preferences in low-and middle-income countries (LMICs) [25]. These specialized surveys present participants with hypothetical scenarios composed of a series of multi-alternative choice profiles.…”
Section: Introductionmentioning
confidence: 99%
“…Patient preferences and WTP for improvements in diabetes treatment have been assessed using Discrete Choice Experiments (DCEs) in the US [23], the Netherlands [24] and Denmark [9], but few published studies have used DCEs to measure diabetes care preferences in low-and middle-income countries (LMICs) [25]. These specialized surveys present participants with hypothetical scenarios composed of a series of multi-alternative choice profiles.…”
Section: Introductionmentioning
confidence: 99%